-
1
-
-
20044381513
-
Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine
-
Haskell CF, Kennedy DO, Wesnes KA, et al. (2005) Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology 179, 813-825.
-
(2005)
Psychopharmacology
, vol.179
, pp. 813-825
-
-
Haskell, C.F.1
Kennedy, D.O.2
Wesnes, K.A.3
-
2
-
-
0031849192
-
Oxygen administration selectively enhances cognitive performance in healthy young adults: A placebo-controlled double-blind crossover study
-
Moss M, Scholey A, Wesnes K (1998) Oxygen administration selectively enhances cognitive performance in healthy young adults: A placebo-controlled double-blind crossover study. Psychopharmacology (Berl) 138, 27-33.
-
(1998)
Psychopharmacology (Berl
, vol.138
, pp. 27-33
-
-
Moss, M.1
Scholey, A.2
Wesnes, K.3
-
3
-
-
0032715146
-
Cognitive performance, hyperoxia, heart rate following oxygen administration in healthy young adults
-
Scholey A, Moss M, Neave N, et al. (1999) Cognitive performance, hyperoxia, heart rate following oxygen administration in healthy young adults. Physiol Behav 67, 783-789.
-
(1999)
Physiol Behav
, vol.67
, pp. 783-789
-
-
Scholey, A.1
Moss, M.2
Neave, N.3
-
4
-
-
29144526744
-
Blood glucose changes and memory: Effects of manipulating emotionality and mental effort
-
Scholey A, Laing S, Kennedy D (2006) Blood glucose changes and memory: Effects of manipulating emotionality and mental effort. Biol Psychol 71, 12-19.
-
(2006)
Biol Psychol
, vol.71
, pp. 12-19
-
-
Scholey, A.1
Laing, S.2
Kennedy, D.3
-
5
-
-
84957630372
-
Multivitamins and minerals modulate whole-body energy metabolism and cerebral blood-flow during cognitive task performance: A double-blind, randomised, placebocontrolled trial
-
Kennedy D, Stevenson E, Jackson P, et al. (2016) Multivitamins and minerals modulate whole-body energy metabolism and cerebral blood-flow during cognitive task performance: A double-blind, randomised, placebocontrolled trial. Nutr Metab 13, 1.
-
(2016)
Nutr Metab
, vol.13
, pp. 1
-
-
Kennedy, D.1
Stevenson, E.2
Jackson, P.3
-
6
-
-
77953032816
-
Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: A double-blind, placebo-controlled, crossover investigation
-
Kennedy D, Wightman EL, Reay JL, et al. (2010) Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: A double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 91, 1590-1597.
-
(2010)
Am J Clin Nutr
, vol.91
, pp. 1590-1597
-
-
Kennedy, D.1
Wightman, E.L.2
Reay, J.L.3
-
7
-
-
84903218648
-
Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in humans: A randomised, double-blind, placebo-controlled, crossover investigation
-
Wightman E, Reay J, Haskell C, et al. (2014) Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in humans: A randomised, double-blind, placebo-controlled, crossover investigation. Br J Nutr 112, 203-213.
-
(2014)
Br J Nutr
, vol.112
, pp. 203-213
-
-
Wightman, E.1
Reay, J.2
Haskell, C.3
-
8
-
-
84944277047
-
The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans
-
Wightman E, Haskell-Ramsay C, Reay J, et al. (2015) The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans. Br J Nutr 114, 1427-1437.
-
(2015)
Br J Nutr
, vol.114
, pp. 1427-1437
-
-
Wightman, E.1
Haskell-Ramsay, C.2
Reay, J.3
-
9
-
-
15244351702
-
Stability, growth, decline in adult life span development of declarative memory: Cross-sectional and longitudinal data from a population-based study
-
Rönnlund M, Nyberg L, Bäckman L, et al. (2005) Stability, growth, decline in adult life span development of declarative memory: Cross-sectional and longitudinal data from a population-based study. Psychol Aging 20, 3-18.
-
(2005)
Psychol Aging
, vol.20
, pp. 3-18
-
-
Rönnlund, M.1
Nyberg, L.2
Bäckman, L.3
-
10
-
-
84963972074
-
2016 Alzheimer's disease facts and figures
-
Association As (2016) 2016 Alzheimer's disease facts and figures. Alzheimer's Demen 12, 459-509.
-
(2016)
Alzheimer's Demen
, vol.12
, pp. 459-509
-
-
As, A.1
-
11
-
-
84941331228
-
-
International AsD An Analysis of Prevalence, Incidence, Cost and Trends. Available at Accessed February 2016
-
International AsD (2015)World Alzheimer Report 2015: The Global Impact of Dementia. An Analysis of Prevalence, Incidence, Cost and Trends. Available at www. alz. co. uk/research/world-report-2015 (Accessed February 2016
-
(2015)
World Alzheimer Report 2015: The Global Impact of Dementia
-
-
-
12
-
-
84920703987
-
Alzheimer's disease risk genes and mechanisms of disease pathogenesis
-
Karch CM, Goate AM(2015) Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77, 43-51.
-
(2015)
Biol Psychiatry
, vol.77
, pp. 43-51
-
-
Karch, C.M.1
Goate, A.M.2
-
13
-
-
4544306972
-
Dietary factors and Alzheimer's disease
-
Luchsinger JA, Mayeux R (2004) Dietary factors and Alzheimer's disease. Lancet Neurol 3, 579-587.
-
(2004)
Lancet Neurol
, vol.3
, pp. 579-587
-
-
Luchsinger, J.A.1
Mayeux, R.2
-
14
-
-
0028365441
-
Smoking and Alzheimer's disease: A review of the epidemiological evidence
-
Lee P (1994) Smoking and Alzheimer's disease: A review of the epidemiological evidence. Neuroepidemiology 13, 131-144.
-
(1994)
Neuroepidemiology
, vol.13
, pp. 131-144
-
-
Lee, P.1
-
15
-
-
84902484347
-
Smoking and increased Alzheimer's disease risk: A review of potential mechanisms
-
Durazzo TC, Mattsson N, WeinerMWet al. (2014) Smoking and increased Alzheimer's disease risk: A review of potential mechanisms. Alzheimer's Demen 10, S122-S145.
-
(2014)
Alzheimer's Demen
, vol.10
, pp. S122-S145
-
-
Durazzo, T.C.1
Mattsson, N.2
Weiner, M.W.3
-
16
-
-
0037454273
-
Prospective study of alcohol consumption and risk of dementia in older adults
-
Mukamal KJ, Kuller LH, Fitzpatrick AL, et al. (2003) Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 289, 1405-1413.
-
(2003)
JAMA
, vol.289
, pp. 1405-1413
-
-
Mukamal, K.J.1
Kuller, L.H.2
Fitzpatrick, A.L.3
-
17
-
-
0030915855
-
Oxidative stress hypothesis in Alzheimer's disease
-
Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23, 134-147.
-
(1997)
Free Radic Biol Med
, vol.23
, pp. 134-147
-
-
Markesbery, W.R.1
-
18
-
-
84878643703
-
Alzheimer's disease and diabetes: New insights and unifying therapies
-
Vignini A, Giulietti A, Nanetti L, et al. (2013) Alzheimer's disease and diabetes: New insights and unifying therapies. Curr Diab Rev 9, 218-227.
-
(2013)
Curr Diab Rev
, vol.9
, pp. 218-227
-
-
Vignini, A.1
Giulietti, A.2
Nanetti, L.3
-
19
-
-
0034603512
-
The role of cerebral ischemia in Alzheimer's disease
-
Kalaria RN (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21, 321-330.
-
(2000)
Neurobiol Aging
, vol.21
, pp. 321-330
-
-
Kalaria, R.N.1
-
20
-
-
84920990009
-
Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: Is RAGE the key
-
Matrone C, Djelloul M, Taglialatela G, et al. (2015) Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: Is RAGE the key. Histol Histopathol 30, 125-139.
-
(2015)
Histol Histopathol
, vol.30
, pp. 125-139
-
-
Matrone, C.1
Djelloul, M.2
Taglialatela, G.3
-
21
-
-
33751074919
-
Metals and Alzheimer's disease
-
Adlard PA, Bush AI (2006) Metals and Alzheimer's disease. J Alzheimer's Dis 10, 145-163.
-
(2006)
J Alzheimer's Dis
, vol.10
, pp. 145-163
-
-
Adlard, P.A.1
Bush, A.I.2
-
22
-
-
84872841524
-
Gender, sex steroid hormones, Alzheimer's disease
-
Vest RS, Pike CJ (2013) Gender, sex steroid hormones, Alzheimer's disease. Horm Behav 63, 301-307.
-
(2013)
Horm Behav
, vol.63
, pp. 301-307
-
-
Vest, R.S.1
Pike, C.J.2
-
23
-
-
84860616458
-
Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease
-
Sattler C, Toro P, Schönknecht P, et al. (2012) Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease. Psychiatry Res 196, 90-95.
-
(2012)
Psychiatry Res
, vol.196
, pp. 90-95
-
-
Sattler, C.1
Toro, P.2
Schönknecht, P.3
-
24
-
-
55849111494
-
Cholinergic system during the progression of Alzheimer's disease: Therapeutic implications
-
Mufson EJ, Counts SE, Perez SE, et al. (2008) Cholinergic system during the progression of Alzheimer's disease: Therapeutic implications. Expert Rev Neurother 8, 1703-1718.
-
(2008)
Expert Rev Neurother
, vol.8
, pp. 1703-1718
-
-
Mufson, E.J.1
Counts, S.E.2
Perez, S.E.3
-
27
-
-
85019329245
-
-
Society As accessed May 2016
-
Society As (2016) Treating behavioural and psychological symptoms of dementia. https://www. alzheimers. org. uk/site/scripts/documents-info. php documentID=1191&pageNumber=2 (accessed May 2016
-
(2016)
Treating Behavioural and Psychological Symptoms of Dementia
-
-
-
28
-
-
84856644400
-
Herbal extracts and phytochemicals: Plant secondary metabolites and the enhancement of human brain function
-
Kennedy D, Wightman E (2011) Herbal extracts and phytochemicals: Plant secondary metabolites and the enhancement of human brain function. Adv Nutr: Int Rev J 2, 32-50.
-
(2011)
Adv Nutr: Int Rev J
, vol.2
, pp. 32-50
-
-
Kennedy, D.1
Wightman, E.2
-
29
-
-
67349099191
-
Ginkgo biloba extract (EGb761® ) influences monoaminergic neurotransmission via inhibition of NE uptake, but notMAO activity after chronic treatment
-
Fehske CJ, Leuner K, Müller WE (2009) Ginkgo biloba extract (EGb761® ) influences monoaminergic neurotransmission via inhibition of NE uptake, but notMAO activity after chronic treatment. Pharmacol Res 60, 68-73.
-
(2009)
Pharmacol Res
, vol.60
, pp. 68-73
-
-
Fehske, C.J.1
Leuner, K.2
Müller, W.E.3
-
30
-
-
34548321002
-
Ginkgo biloba leave extract: Biological, medicinal, toxicological effects
-
Chan PC, Xia QS, Fu PP (2007) Ginkgo biloba leave extract: Biological, medicinal, toxicological effects. J Environ Sci Health C: Environ Carcinog Ecotoxicol Rev 25, 211-244.
-
(2007)
J Environ Sci Health C: Environ Carcinog Ecotoxicol Rev
, vol.25
, pp. 211-244
-
-
Chan, P.C.1
Xia, Q.S.2
Fu, P.P.3
-
31
-
-
7644229150
-
Stress-alleviating" and "vigilance-enhancing" actions of Ginkgo biloba extract (EGb 761)
-
DeFeudis FV, Drieu K (2004) "Stress-alleviating" and "vigilance-enhancing" actions of Ginkgo biloba extract (EGb 761). Drug Dev Res 62, 1-25.
-
(2004)
Drug Dev Res
, vol.62
, pp. 1-25
-
-
DeFeudis, F.V.1
Drieu, K.2
-
32
-
-
84887395473
-
Ginkgo leaf extract
-
Berger P (2001) Ginkgo leaf extract. Med Herbal. 2, 5-6.
-
(2001)
Med Herbal
, vol.2
, pp. 5-6
-
-
Berger, P.1
-
33
-
-
0344826082
-
Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment
-
Stackman RW, Eckenstein F, Frei B, et al. (2003) Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol 184, 510-520.
-
(2003)
Exp Neurol
, vol.184
, pp. 510-520
-
-
Stackman, R.W.1
Eckenstein, F.2
Frei, B.3
-
34
-
-
0242467845
-
Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761
-
Smith JV, Luo Y (2003) Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimer's Dis 5, 287-300.
-
(2003)
J Alzheimer's Dis
, vol.5
, pp. 287-300
-
-
Smith, J.V.1
Luo, Y.2
-
35
-
-
0043150950
-
Ginkgo biloba for cognitive impairment and dementia
-
Available at onlinelibrary. Wiley com/doi/10.1002/14651858. CD003120 (Accessed February 2016
-
Birks J, Grimley Evans J (2002) Ginkgo biloba for cognitive impairment and dementia. The Cochrane Library. Available at onlinelibrary. wiley. com/doi/10. 1002/14651858. CD003120 (Accessed February 2016
-
(2002)
The Cochrane Library
-
-
Birks, J.1
Grimley Evans, J.2
-
36
-
-
69549105254
-
Ginkgo biloba for cognitive impairment and dementia
-
Available at onlinelibrary.wiley com/doi/10. 1002/14651858. CD003120. PUB3/FULL (Accessed February 2016
-
Birks J, Evans JG (2009) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. Available at onlinelibrary. wiley. com/doi/10. 1002/14651858. CD003120. PUB3/FULL (Accessed February 2016
-
(2009)
Cochrane Database Syst Rev
-
-
Birks, J.1
Evans, J.G.2
-
37
-
-
73949086506
-
Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial
-
Snitz BE, O'Meara ES, Carlson MC, et al. (2009) Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial. JAMA 302, 2663.
-
(2009)
JAMA
, vol.302
, pp. 2663
-
-
Snitz, B.E.1
O'Meara, E.S.2
Carlson, M.C.3
-
38
-
-
77950278582
-
Effects of Ginkgo biloba in dementia: Systematic review and meta-analysis
-
Weinmann S, Roll S, Schwarzbach C, et al. (2010) Effects of Ginkgo biloba in dementia: Systematic review and meta-analysis. BMC Geriatr 10, 1.
-
(2010)
BMC Geriatr
, vol.10
, pp. 1
-
-
Weinmann, S.1
Roll, S.2
Schwarzbach, C.3
-
39
-
-
77952046577
-
Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: A bivariate random effect meta-analysis
-
Wang B, Wang H, Song Y, et al. (2010) Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: A bivariate random effect meta-analysis. Pharmacopsychiatry 43, 86-91.
-
(2010)
Pharmacopsychiatry
, vol.43
, pp. 86-91
-
-
Wang, B.1
Wang, H.2
Song, Y.3
-
41
-
-
0035650950
-
Brief introduction of Panax ginseng CA Meyer
-
Yun TK (2001) Brief introduction of Panax ginseng CA Meyer. J Korean Med Sci 16, 3-5.
-
(2001)
J Korean Med Sci
, vol.16
, pp. 3-5
-
-
Yun, T.K.1
-
42
-
-
0002705849
-
Saponins and plant defence-a soap story
-
Osbourn A (1996) Saponins and plant defence-a soap story. Trends Plant Sci 1, 4-9.
-
(1996)
Trends Plant Sci
, vol.1
, pp. 4-9
-
-
Osbourn, A.1
-
43
-
-
4344587843
-
Biological activities and distribution of plant saponins
-
Sparg SG, Light ME, van Staden J (2004) Biological activities and distribution of plant saponins. J Ethnopharmacol 94, 219-243.
-
(2004)
J Ethnopharmacol
, vol.94
, pp. 219-243
-
-
Sparg, S.G.1
Light, M.E.2
Van Staden, J.3
-
44
-
-
69149110615
-
Ginseng compounds: An update on their molecular mechanisms and medical applications
-
Lu JM, Yao QZ, Chen CY (2009) Ginseng compounds: An update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 7, 293-302.
-
(2009)
Curr Vasc Pharmacol
, vol.7
, pp. 293-302
-
-
Lu, J.M.1
Yao, Q.Z.2
Chen, C.Y.3
-
45
-
-
0344549853
-
Ginseng pharmacology: Multiple constituents and multiple actions
-
Attele AS, Wu JA, Yuan C-S (1999) Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58, 1685-1693.
-
(1999)
Biochem Pharmacol
, vol.58
, pp. 1685-1693
-
-
Attele, A.S.1
Wu, J.A.2
Yuan, C.-S.3
-
46
-
-
71549173390
-
Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression
-
Dang HX, Chen Y, Liu XM, et al. (2009) Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Progr Neuro-Psychopharmacol Biol Psychiatry 33, 1417-1424.
-
(2009)
Progr Neuro-Psychopharmacol Biol Psychiatry
, vol.33
, pp. 1417-1424
-
-
Dang, H.X.1
Chen, Y.2
Liu, X.M.3
-
47
-
-
0035195054
-
Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers
-
Kennedy D, Scholey AB, Wesnes KA (2001) Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr Neurosci 4, 399-412.
-
(2001)
Nutr Neurosci
, vol.4
, pp. 399-412
-
-
Kennedy, D.1
Scholey, A.B.2
Wesnes, K.A.3
-
48
-
-
0037088968
-
Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, a ginkgo/ginseng combination to healthy young adults
-
Kennedy D, Scholey AB, Wesnes KA (2002) Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, a ginkgo/ginseng combination to healthy young adults. Physiol Behav 75, 739-751.
-
(2002)
Physiol Behav
, vol.75
, pp. 739-751
-
-
Kennedy, D.1
Scholey, A.B.2
Wesnes, K.A.3
-
49
-
-
22344436485
-
Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity
-
Reay JL, Kennedy DO, Scholey AB (2005) Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol 19, 357-365.
-
(2005)
J Psychopharmacol
, vol.19
, pp. 357-365
-
-
Reay, J.L.1
Kennedy, D.O.2
Scholey, A.B.3
-
50
-
-
77956570404
-
Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults
-
Reay JL, Scholey AB, Kennedy DO (2010) Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Human Psychopharmacol: Clin Exp 25, 462-471.
-
(2010)
Human Psychopharmacol: Clin Exp
, vol.25
, pp. 462-471
-
-
Reay, J.L.1
Scholey, A.B.2
Kennedy, D.O.3
-
51
-
-
0034809475
-
Effect of ginseng saponins on b-amyloid-suppressed acetylcholine release from rat hippocampal slices
-
Lee T, Shiao Y-J, Chen C-F, et al. (2001) Effect of ginseng saponins on b-amyloid-suppressed acetylcholine release from rat hippocampal slices. Planta Med 67, 634-637.
-
(2001)
Planta Med
, vol.67
, pp. 634-637
-
-
Lee, T.1
Shiao, Y.-J.2
Chen, C.-F.3
-
52
-
-
27944490908
-
Effects of ginseng saponins on-amyloid-induced amnesia in rats
-
Wang LC, Wang B, Ng S-Y, et al. (2006) Effects of ginseng saponins on-amyloid-induced amnesia in rats. J Ethnopharmacol 103, 103-108.
-
(2006)
J Ethnopharmacol
, vol.103
, pp. 103-108
-
-
Wang, L.C.1
Wang, B.2
Ng, S.-Y.3
-
53
-
-
54549111180
-
An openlabel trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease
-
Heo JH, Lee ST, Chu K, et al. (2008) An openlabel trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur J Neurol 15, 865-868.
-
(2008)
Eur J Neurol
, vol.15
, pp. 865-868
-
-
Heo, J.H.1
Lee, S.T.2
Chu, K.3
-
54
-
-
84930478521
-
Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with Korean red ginseng
-
Heo J-H, Lee S-T, Oh M-J, et al. (2011) Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with Korean red ginseng. J Ginseng Res 35, 457-461.
-
(2011)
J Ginseng Res
, vol.35
, pp. 457-461
-
-
Heo, J.-H.1
Lee, S.-T.2
Oh, M.-J.3
-
55
-
-
33751538587
-
The psychopharmacology of European herbs with cognition-enhancing properties
-
Kennedy D, Scholey AB (2006) The psychopharmacology of European herbs with cognition-enhancing properties. Curr Pharm Des 12, 4613-4623.
-
(2006)
Curr Pharm des
, vol.12
, pp. 4613-4623
-
-
Kennedy, D.1
Scholey, A.B.2
-
56
-
-
0020363954
-
Chemical-composition of the essential oil from Melissa
-
Tittel G, Wagner H, Bos R (1982) Chemical-composition of the essential oil from Melissa. Planta Med 46, 91-98.
-
(1982)
Planta Med
, vol.46
, pp. 91-98
-
-
Tittel, G.1
Wagner, H.2
Bos, R.3
-
57
-
-
33749324270
-
The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal
-
Ferreira A, Proencą C, Serralheiro M, et al. (2006) The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J Ethnopharmacol 108, 31-37.
-
(2006)
J Ethnopharmacol
, vol.108
, pp. 31-37
-
-
Ferreira, A.1
Proencą, C.2
Serralheiro, M.3
-
58
-
-
84984535982
-
Antioxidant effects of different extracts from Melissa officinalis Matricaria recutita and Cymbopogon citratus
-
Pereira RP, Fachinetto R, de Souza Prestes A, et al. (2009) Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem Res 34, 973-983.
-
(2009)
Neurochem Res
, vol.34
, pp. 973-983
-
-
Pereira, R.P.1
Fachinetto, R.2
De Souza Prestes, A.3
-
59
-
-
0030447932
-
European herbs with cholinergic activities: Potential in dementia therapy
-
Perry N, Court G, Bidet N, et al. (1996) European herbs with cholinergic activities: Potential in dementia therapy. Int J Geriatr Psychiatry 11, 1063-1069.
-
(1996)
Int J Geriatr Psychiatry
, vol.11
, pp. 1063-1069
-
-
Perry, N.1
Court, G.2
Bidet, N.3
-
60
-
-
0034141539
-
CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory
-
Wake G (2000) CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J Ethnopharmacol 69, 105-114.
-
(2000)
J Ethnopharmacol
, vol.69
, pp. 105-114
-
-
Wake, G.1
-
61
-
-
58549083537
-
Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L
-
Dastmalchi K, Ollilainen V, Lackman P, et al. (2009) Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L. Bioorg Med Chem 17, 867-871.
-
(2009)
Bioorg Med Chem
, vol.17
, pp. 867-871
-
-
Dastmalchi, K.1
Ollilainen, V.2
Lackman, P.3
-
62
-
-
67649833545
-
Bioassay-guided fractionation of Lemon balm (Melissa officinalis L. ) using an in Vitro measure of GABA transaminase activity
-
Awad R, Muhammad A, Durst T, et al. (2009) Bioassay-guided fractionation of Lemon balm (Melissa officinalis L. ) using an in Vitro measure of GABA transaminase activity. Phytother Res 23, 1075-1081.
-
(2009)
Phytother Res
, vol.23
, pp. 1075-1081
-
-
Awad, R.1
Muhammad, A.2
Durst, T.3
-
63
-
-
0038141740
-
Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial
-
Akhondzadeh S, Noroozian M, Mohammadi M, et al. (2003) Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatry 74, 863-866.
-
(2003)
J Neurol Neurosurg Psychiatry
, vol.74
, pp. 863-866
-
-
Akhondzadeh, S.1
Noroozian, M.2
Mohammadi, M.3
-
64
-
-
0036076832
-
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa
-
Ballard CG, O'Brien JT, Reichelt K, et al. (2002) Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry 63, 553-558.
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 553-558
-
-
Ballard, C.G.1
O'Brien, J.T.2
Reichelt, K.3
-
65
-
-
0042855802
-
Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil
-
Savelev S, Okello E, Perry N, et al. (2003) Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil. Pharmacol Biochem Behav 75, 661-668.
-
(2003)
Pharmacol Biochem Behav
, vol.75
, pp. 661-668
-
-
Savelev, S.1
Okello, E.2
Perry, N.3
-
66
-
-
2442421009
-
Butyryl-A nd acetylcholinesterase inhibitory activities in essential oils of Salvia species and their constituents
-
Savelev S, Okello E, Perry E (2004) Butyryl-A nd acetylcholinesterase inhibitory activities in essential oils of Salvia species and their constituents. Phytother Res 18, 315-324.
-
(2004)
Phytother Res
, vol.18
, pp. 315-324
-
-
Savelev, S.1
Okello, E.2
Perry, E.3
-
67
-
-
0033913221
-
In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes
-
Perry N, Houghton P, Theobald A, et al. (2000) In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 52, 895-902
-
(2000)
J Pharm Pharmacol
, vol.52
, pp. 895-902
-
-
Perry, N.1
Houghton, P.2
Theobald, A.3
-
69
-
-
43049129922
-
An extract of Salvia sage with anticholinesterase properties improves memory and attention in healthy older volunteers
-
Scholey A, Tildesley N, Ballard C, et al. (2008) An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology 198, 127-139.
-
(2008)
Psychopharmacology
, vol.198
, pp. 127-139
-
-
Scholey, A.1
Tildesley, N.2
Ballard, C.3
-
70
-
-
0042197464
-
Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial
-
Perry N, Bollen C, Perry E, et al. (2003) Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 75, 651-659.
-
(2003)
Pharmacol Biochem Behav
, vol.75
, pp. 651-659
-
-
Perry, N.1
Bollen, C.2
Perry, E.3
-
71
-
-
0037293995
-
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial
-
Akhondzadeh S, Noroozian M, Mohammadi M, et al. (2003) Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28, 53-59.
-
(2003)
J Clin Pharm Ther
, vol.28
, pp. 53-59
-
-
Akhondzadeh, S.1
Noroozian, M.2
Mohammadi, M.3
-
72
-
-
0033863355
-
Dietary intake and bioavailability of polyphenols
-
Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S-2085S.
-
(2000)
J Nutr
, vol.130
, pp. 2073S-2085S
-
-
Scalbert, A.1
Williamson, G.2
-
73
-
-
34548656056
-
Dietary patterns and risk of dementia the three-city cohort study
-
Barberger-Gateau P, Raffaitin C, Letenneur L, et al. (2007) Dietary patterns and risk of dementia the three-city cohort study. Neurology 69, 1921-1930.
-
(2007)
Neurology
, vol.69
, pp. 1921-1930
-
-
Barberger-Gateau, P.1
Raffaitin, C.2
Letenneur, L.3
-
74
-
-
0033835543
-
Intake of flavonoids and risk of dementia
-
Commenges D, Scotet V, Renaud S, et al. (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16, 357-363.
-
(2000)
Eur J Epidemiol
, vol.16
, pp. 357-363
-
-
Commenges, D.1
Scotet, V.2
Renaud, S.3
-
75
-
-
34547434761
-
Flavonoid intake and cognitive decline over a 10-year period
-
Letenneur L, Proust-Lima C, Le Gouge A, et al. (2007) Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 165, 1364-1371.
-
(2007)
Am J Epidemiol
, vol.165
, pp. 1364-1371
-
-
Letenneur, L.1
Proust-Lima, C.2
Le Gouge, A.3
-
76
-
-
47249129974
-
Tea consumption and cognitive impairment and decline in older Chinese adults
-
Ng T, Feng L, Niti M, et al. (2008) Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 88, 224-231.
-
(2008)
Am J Clin Nutr
, vol.88
, pp. 224-231
-
-
Ng, T.1
Feng, L.2
Niti, M.3
-
77
-
-
33644858479
-
Green tea consumption and cognitive function: A cross-sectional study from the Tsurugaya Project 1
-
Kuriyama S, Hozawa A, Ohmori K, et al. (2006) Green tea consumption and cognitive function: A cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr 83, 355.
-
(2006)
Am J Clin Nutr
, vol.83
, pp. 355
-
-
Kuriyama, S.1
Hozawa, A.2
Ohmori, K.3
-
78
-
-
58649124965
-
Intake of flavonoid-rich wine, tea, chocolate by elderly men and women is associated with better cognitive test performance
-
Nurk E, Refsum H, Drevon CA, et al. (2009) Intake of flavonoid-rich wine, tea, chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 139, 120-127.
-
(2009)
J Nutr
, vol.139
, pp. 120-127
-
-
Nurk, E.1
Refsum, H.2
Drevon, C.A.3
-
79
-
-
84937532657
-
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
-
Zordoky BN, Robertson IM, Dyck JR (2015) Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta 1852, 1155-1177.
-
(2015)
Biochim Biophys Acta
, vol.1852
, pp. 1155-1177
-
-
Zordoky, B.N.1
Robertson, I.M.2
Dyck, J.R.3
-
81
-
-
84866675912
-
The effect of resveratrol on longevity across species: A meta-analysis
-
Hector KL, Lagisz M, Nakagawa S (2012) The effect of resveratrol on longevity across species: A meta-analysis. Biol Lett 8, 790-793.
-
(2012)
Biol Lett
, vol.8
, pp. 790-793
-
-
Hector, K.L.1
Lagisz, M.2
Nakagawa, S.3
-
82
-
-
84932144505
-
Direct molecular targets of resveratrol: Identifying key interactions to unlock complex mechanisms
-
Britton RG, Kovoor C, Brown K (2015) Direct molecular targets of resveratrol: Identifying key interactions to unlock complex mechanisms. Ann N Y Acad Sci 1348, 124-133.
-
(2015)
Ann N y Acad Sci
, vol.1348
, pp. 124-133
-
-
Britton, R.G.1
Kovoor, C.2
Brown, K.3
-
83
-
-
1942472491
-
Neuroprotective effects of resveratrol against amyloidinduced neurotoxicity in rat hippocampal neurons: Involvement of protein kinase C
-
Han YS, Zheng WH, Bastianetto S, et al. (2004) Neuroprotective effects of resveratrol against amyloidinduced neurotoxicity in rat hippocampal neurons: Involvement of protein kinase C. Br J Pharmacol 141, 997-1005.
-
(2004)
Br J Pharmacol
, vol.141
, pp. 997-1005
-
-
Han, Y.S.1
Zheng, W.H.2
Bastianetto, S.3
-
84
-
-
60249098801
-
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
-
Karuppagounder SS, Pinto JT, Xu H, et al. (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem Int 54, 111-118.
-
(2009)
Neurochem Int
, vol.54
, pp. 111-118
-
-
Karuppagounder, S.S.1
Pinto, J.T.2
Xu, H.3
-
85
-
-
84886703858
-
Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia
-
Ma X, Sun Z, Liu Y, et al. (2013) Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia. Neural Regen Res 8, 2050.
-
(2013)
Neural Regen Res
, vol.8
, pp. 2050
-
-
Ma, X.1
Sun, Z.2
Liu, Y.3
-
86
-
-
85019339818
-
Resveratrol is safe and well-tolerated in individuals with mild-moderate dementia due to Alzheimer's disease
-
Turner R, Thomas R, Craft S, et al. (2015) Resveratrol is safe and well-tolerated in individuals with mild-moderate dementia due to Alzheimer's disease. Neurology 84, Supplement 33-009.
-
(2015)
Neurology
, vol.84
, pp. 009-33
-
-
Turner, R.1
Thomas, R.2
Craft, S.3
|